Onyx injection by direct puncture for presurgical embolization of a C2 hypervascular metastasis from a thyroid cancer.
cervical
liquid embolic material
spine
tumor
Journal
Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
02
12
2020
revised:
09
02
2021
accepted:
13
02
2021
pubmed:
25
3
2021
medline:
21
1
2022
entrez:
24
3
2021
Statut:
ppublish
Résumé
Surgery for spinal hypervascular lesions, such as hemangioma or metastases from thyroid or renal cancer, may be challenging because of the risk of massive blood loss.1 To overcome this limitation, presurgical embolization has gained acceptance to reduce this risk.2 However, some configurations, such as the origin of a radiculomedullary artery close to the vessels feeding the lesion or when the lesion is supplied by vessels feeding an eloquent territory, may limit the possibility of presurgical embolization, especially with microparticles.3 Direct percutaneous puncture of the spinal lesion and subsequent embolization with liquid embolic agent may be a valuable option in such challenging cases.4 We present a case of presurgical embolization of a C2 metastasis from a thyroid cancer using Onyx-18 injected by direct puncture (video 1). In this technical video, we stress the technical aspects of the direct puncture technique and the safety rules to avoid neurological complications. neurintsurg;14/1/neurintsurg-2020-017180/V1F1V1Video 1.
Identifiants
pubmed: 33758068
pii: neurintsurg-2020-017180
doi: 10.1136/neurintsurg-2020-017180
pii:
doi:
Substances chimiques
Polyvinyls
0
Types de publication
Case Reports
Journal Article
Video-Audio Media
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: FC reports conflicts of interest with Medtronic, Guerbet, Balt Extrusion, Penumbra (payment for readings; not related to the study), Codman Neurovascular, and Microvention (core lab; not related to the study).